Komipharm International Company Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Komipharm International Company Limited with three other
companies in this sector in South Korea:
Choong Ang Vaccine Laboratory
sales of 33.15 billion Korean Won [US$28.41 million]
of which 100%
was Animal Health Product),
G-treeBNT Co Ltd
(46.36 billion Korean Won [US$39.73 million]
of which 61%
was Medicine), and
Eu Biologics Co Ltd
(24.89 billion Korean Won [US$21.33 million]
of which 91%
Komipharm International Company Limited reported sales of 34.99 billion Korean Won (US$29.99 million)
December of 2018.
decrease of 4.5%
versus 2017, when the company's sales were 36.64 billion Korean Won.